Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 693 entries
Sorted by: Best Match Show Resources per page
Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C.

International journal of organ transplantation medicine

Saidi RF, Hertl M, Chung RT, Ko DS, Kawai T, Markmann J, Bhan AK, Cosimi AB, Elias N.
PMID: 25013609
Int J Organ Transplant Med. 2011;2(4):160-5.

BACKGROUND: Hepatitis C (HCV) is the most common indication for liver transplantation in the US.OBJECTIVE: Since steroids are the major stimulus of viral replication, we postulated that steroid-free immunosuppression might be a safer approach.METHODS: From January 1995 to October...

Cite
Saidi RF, Hertl M, Chung RT, et al. Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C. Int J Organ Transplant Med. 2011;2(4):160-5
Saidi, R. F., Hertl, M., Chung, R. T., Ko, D. S., Kawai, T., Markmann, J., Bhan, A. K., Cosimi, A. B., & Elias, N. (2011). Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C. International journal of organ transplantation medicine, 2(4), 160-5.
Saidi, R F, et al. "Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C." International journal of organ transplantation medicine vol. 2,4 (2011): 160-5.
Saidi RF, Hertl M, Chung RT, Ko DS, Kawai T, Markmann J, Bhan AK, Cosimi AB, Elias N. Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C. Int J Organ Transplant Med. 2011;2(4):160-5. PMID: 25013609; PMCID: PMC4089267.
Copy Download .nbib Format: NLM
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma.

American journal of human genetics

Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C, Brennan P, Hung R, Gaborieau V, McKay JD, Lathrop M, McLaughlin J, Wang Y, Tsao MS, Spitz MR, Wang Y, Krokan H, Vatten L, Skorpen F, Arnesen E, Benhamou S, Bouchard C, Metspalu A, Vooder T, Nelis M, Välk K, Field JK, Chen C, Goodman G, Sulem P, Thorleifsson G, Rafnar T, Eisen T, Sauter W, Rosenberger A, Bickeböller H, Risch A, Chang-Claude J, Wichmann HE, Stefansson K, Houlston R, Amos CI, Fraumeni JF, Savage SA, Bertazzi PA, Tucker MA, Chanock S, Caporaso NE.
PMID: 28472664
Am J Hum Genet. 2011 Jun 10;88(6):861. doi: 10.1016/j.ajhg.2011.05.003. Epub 2011 Jun 10.

No abstract available.

Cite
Landi MT, Chatterjee N, Yu K, et al. A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. Am J Hum Genet. 2011;88(6):861doi: 10.1016/j.ajhg.2011.05.003.
Landi, M. T., Chatterjee, N., Yu, K., Goldin, L. R., Goldstein, A. M., Rotunno, M., Mirabello, L., Jacobs, K., Wheeler, W., Yeager, M., Bergen, A. W., Li, Q., Consonni, D., Pesatori, A. C., Wacholder, S., Thun, M., Diver, R., Oken, M., Virtamo, J., Albanes, D., Wang, Z., Burdette, L., Doheny, K. F., Pugh, E. W., Laurie, C., Brennan, P., Hung, R., Gaborieau, V., McKay, J. D., Lathrop, M., McLaughlin, J., Wang, Y., Tsao, M. S., Spitz, M. R., Wang, Y., Krokan, H., Vatten, L., Skorpen, F., Arnesen, E., Benhamou, S., Bouchard, C., Metspalu, A., Vooder, T., Nelis, M., Välk, K., Field, J. K., Chen, C., Goodman, G., Sulem, P., Thorleifsson, G., Rafnar, T., Eisen, T., Sauter, W., Rosenberger, A., Bickeböller, H., Risch, A., Chang-Claude, J., Wichmann, H. E., Stefansson, K., Houlston, R., Amos, C. I., Fraumeni, J. F., Savage, S. A., Bertazzi, P. A., Tucker, M. A., Chanock, S., & Caporaso, N. E. (2011). A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. American journal of human genetics, 88(6), 861. https://doi.org/10.1016/j.ajhg.2011.05.003
Landi, Maria Teresa, et al. "A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma." American journal of human genetics vol. 88,6 (2011): 861. doi: https://doi.org/10.1016/j.ajhg.2011.05.003
Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C, Brennan P, Hung R, Gaborieau V, McKay JD, Lathrop M, McLaughlin J, Wang Y, Tsao MS, Spitz MR, Wang Y, Krokan H, Vatten L, Skorpen F, Arnesen E, Benhamou S, Bouchard C, Metspalu A, Vooder T, Nelis M, Välk K, Field JK, Chen C, Goodman G, Sulem P, Thorleifsson G, Rafnar T, Eisen T, Sauter W, Rosenberger A, Bickeböller H, Risch A, Chang-Claude J, Wichmann HE, Stefansson K, Houlston R, Amos CI, Fraumeni JF, Savage SA, Bertazzi PA, Tucker MA, Chanock S, Caporaso NE. A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. Am J Hum Genet. 2011 Jun 10;88(6):861. doi: 10.1016/j.ajhg.2011.05.003. Epub 2011 Jun 10. PMID: 28472664; PMCID: PMC3113243.
Copy Download .nbib Format: NLM
Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar.

Public health action

Thi AM, Shewade HD, Kyaw NT, Oo MM, Aung TK, Aung ST, Oo HN, Win T, Harries AD.
PMID: 27358804
Public Health Action. 2016 Jun 21;6(2):111-7. doi: 10.5588/pha.16.0009.

SETTING: Integrated HIV Care programme, Mandalay, Myanmar.OBJECTIVES: To determine time to starting antiretroviral treatment (ART) in relation to anti-tuberculosis treatment (ATT) and its association with TB treatment outcomes in patients co-infected with tuberculosis (TB) and the human immunodeficiency virus...

Cite
Thi AM, Shewade HD, Kyaw NT, et al. Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar. Public Health Action. 2016;6(2):111-7doi: 10.5588/pha.16.0009.
Thi, A. M., Shewade, H. D., Kyaw, N. T., Oo, M. M., Aung, T. K., Aung, S. T., Oo, H. N., Win, T., & Harries, A. D. (2016). Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar. Public health action, 6(2), 111-7. https://doi.org/10.5588/pha.16.0009
Thi, A M, et al. "Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar." Public health action vol. 6,2 (2016): 111-7. doi: https://doi.org/10.5588/pha.16.0009
Thi AM, Shewade HD, Kyaw NT, Oo MM, Aung TK, Aung ST, Oo HN, Win T, Harries AD. Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar. Public Health Action. 2016 Jun 21;6(2):111-7. doi: 10.5588/pha.16.0009. PMID: 27358804; PMCID: PMC4913673.
Copy Download .nbib Format: NLM
Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study.

International journal of nephrology

Allegretti AS, Ortiz G, Wenger J, Deferio JJ, Wibecan J, Kalim S, Tamez H, Chung RT, Karumanchi SA, Thadhani RI.
PMID: 26266048
Int J Nephrol. 2015;2015:108139. doi: 10.1155/2015/108139. Epub 2015 Jul 22.

Background/Aims. Acute kidney injury is a common problem for patients with cirrhosis and is associated with poor survival. We aimed to examine the association between type of acute kidney injury and 90-day mortality. Methods. Prospective cohort study at a...

Cite
Allegretti AS, Ortiz G, Wenger J, et al. Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study. Int J Nephrol. 2015;2015:108139doi: 10.1155/2015/108139.
Allegretti, A. S., Ortiz, G., Wenger, J., Deferio, J. J., Wibecan, J., Kalim, S., Tamez, H., Chung, R. T., Karumanchi, S. A., & Thadhani, R. I. (2015). Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study. International journal of nephrology, 2015108139. https://doi.org/10.1155/2015/108139
Allegretti, Andrew S, et al. "Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study." International journal of nephrology vol. 2015 (2015): 108139. doi: https://doi.org/10.1155/2015/108139
Allegretti AS, Ortiz G, Wenger J, Deferio JJ, Wibecan J, Kalim S, Tamez H, Chung RT, Karumanchi SA, Thadhani RI. Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study. Int J Nephrol. 2015;2015:108139. doi: 10.1155/2015/108139. Epub 2015 Jul 22. PMID: 26266048; PMCID: PMC4525763.
Copy Download .nbib Format: NLM
Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.

Nature genetics

Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, Vallée M, Le Calvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Njølstad I, Chen C, Goodman G, Benhamou S, Vooder T, Välk K, Nelis M, Metspalu A, Lener M, Lubiński J, Johansson M, Vineis P, Agudo A, Clavel-Chapelon F, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Johansson M, Weiderpass E, Tjønneland A, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Rosenberger A, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI.
PMID: 28358128
Nat Genet. 2017 Mar 30;49(4):651. doi: 10.1038/ng0417-651a.

No abstract available.

Cite
Wang Y, McKay JD, Rafnar T, et al. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2017;49(4):651doi: 10.1038/ng0417-651a.
Wang, Y., McKay, J. D., Rafnar, T., Wang, Z., Timofeeva, M. N., Broderick, P., Zong, X., Laplana, M., Wei, Y., Han, Y., Lloyd, A., Delahaye-Sourdeix, M., Chubb, D., Gaborieau, V., Wheeler, W., Chatterjee, N., Thorleifsson, G., Sulem, P., Liu, G., Kaaks, R., Henrion, M., Kinnersley, B., Vallée, M., Le Calvez-Kelm, F., Stevens, V. L., Gapstur, S. M., Chen, W. V., Zaridze, D., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., Fabianova, E., Mates, D., Bencko, V., Foretova, L., Janout, V., Krokan, H. E., Gabrielsen, M. E., Skorpen, F., Vatten, L., Njølstad, I., Chen, C., Goodman, G., Benhamou, S., Vooder, T., Välk, K., Nelis, M., Metspalu, A., Lener, M., Lubiński, J., Johansson, M., Vineis, P., Agudo, A., Clavel-Chapelon, F., Bueno-de-Mesquita, H. B., Trichopoulos, D., Khaw, K. T., Johansson, M., Weiderpass, E., Tjønneland, A., Riboli, E., Lathrop, M., Scelo, G., Albanes, D., Caporaso, N. E., Ye, Y., Gu, J., Wu, X., Spitz, M. R., Dienemann, H., Rosenberger, A., Su, L., Matakidou, A., Eisen, T., Stefansson, K., Risch, A., Chanock, S. J., Christiani, D. C., Hung, R. J., Brennan, P., Landi, M. T., Houlston, R. S., & Amos, C. I. (2017). Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nature genetics, 49(4), 651. https://doi.org/10.1038/ng0417-651a
Wang, Yufei, et al. "Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer." Nature genetics vol. 49,4 (2017): 651. doi: https://doi.org/10.1038/ng0417-651a
Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, Vallée M, Le Calvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Njølstad I, Chen C, Goodman G, Benhamou S, Vooder T, Välk K, Nelis M, Metspalu A, Lener M, Lubiński J, Johansson M, Vineis P, Agudo A, Clavel-Chapelon F, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Johansson M, Weiderpass E, Tjønneland A, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Rosenberger A, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2017 Mar 30;49(4):651. doi: 10.1038/ng0417-651a. PMID: 28358128.
Copy Download .nbib Format: NLM
MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD).

Hepatology communications

Simon TG, Kartoun U, Zheng H, Chan AT, Chung RT, Shaw S, Corey KE.
PMID: 29085919
Hepatol Commun. 2017 Jul;1(5):429-438. doi: 10.1002/hep4.1051. Epub 2017 May 22.

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of mortality among adults with nonalcoholic fatty liver disease (NAFLD), however accurate tools for identifying NAFLD patients at highest CVD risk are lacking.METHODS: Using a validated algorithm, we identified a retrospective...

Cite
Simon TG, Kartoun U, Zheng H, et al. MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD). Hepatol Commun. 2017;1(5):429-438doi: 10.1002/hep4.1051.
Simon, T. G., Kartoun, U., Zheng, H., Chan, A. T., Chung, R. T., Shaw, S., & Corey, K. E. (2017). MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD). Hepatology communications, 1(5), 429-438. https://doi.org/10.1002/hep4.1051
Simon, Tracey G, et al. "MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD)." Hepatology communications vol. 1,5 (2017): 429-438. doi: https://doi.org/10.1002/hep4.1051
Simon TG, Kartoun U, Zheng H, Chan AT, Chung RT, Shaw S, Corey KE. MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD). Hepatol Commun. 2017 Jul;1(5):429-438. doi: 10.1002/hep4.1051. Epub 2017 May 22. PMID: 29085919; PMCID: PMC5659323.
Copy Download .nbib Format: NLM
Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy.

Kidney international reports

Sise ME, Wisocky J, Rosales IA, Chute D, Holmes JA, Corapi KM, Babitt JL, Tangren JS, Hashemi N, Lundquist AL, Williams WW, Mount DB, Andersson KL, Rennke HG, Smith RN, Colvin R, Thadhani RI, Chung RT.
PMID: 27990496
Kidney Int Rep. 2016 Sep;1(3):135-143. doi: 10.1016/j.ekir.2016.06.006.

Novel, all-oral interferon-free direct-acting antiviral agents have revolutionized the management of hepatitis C virus (HCV) infection by producing exceptional cure rates with minimal adverse events. While provocation or exacerbation of autoimmunity has been reported in HCV-infected patients receiving interferon,...

Cite
Sise ME, Wisocky J, Rosales IA, et al. Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy. Kidney Int Rep. 2016;1(3):135-143doi: 10.1016/j.ekir.2016.06.006.
Sise, M. E., Wisocky, J., Rosales, I. A., Chute, D., Holmes, J. A., Corapi, K. M., Babitt, J. L., Tangren, J. S., Hashemi, N., Lundquist, A. L., Williams, W. W., Mount, D. B., Andersson, K. L., Rennke, H. G., Smith, R. N., Colvin, R., Thadhani, R. I., & Chung, R. T. (2016). Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy. Kidney international reports, 1(3), 135-143. https://doi.org/10.1016/j.ekir.2016.06.006
Sise, Meghan E, et al. "Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy." Kidney international reports vol. 1,3 (2016): 135-143. doi: https://doi.org/10.1016/j.ekir.2016.06.006
Sise ME, Wisocky J, Rosales IA, Chute D, Holmes JA, Corapi KM, Babitt JL, Tangren JS, Hashemi N, Lundquist AL, Williams WW, Mount DB, Andersson KL, Rennke HG, Smith RN, Colvin R, Thadhani RI, Chung RT. Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy. Kidney Int Rep. 2016 Sep;1(3):135-143. doi: 10.1016/j.ekir.2016.06.006. PMID: 27990496; PMCID: PMC5155703.
Copy Download .nbib Format: NLM
Common gas phase molecules from fungi affect seed germination and plant health in Arabidopsis thaliana.

AMB Express

Hung R, Lee S, Rodriguez-Saona C, Bennett JW.
PMID: 25045602
AMB Express. 2014 Jul 15;4:53. doi: 10.1186/s13568-014-0053-8. eCollection 2014.

Fungal volatile organic compounds (VOCs) play important ecophysiological roles in mediating inter-kingdom signaling with arthropods but less is known about their interactions with plants. In this study, Arabidopsis thaliana was used as a model in order to test the...

Cite
Hung R, Lee S, Rodriguez-Saona C, et al. Common gas phase molecules from fungi affect seed germination and plant health in Arabidopsis thaliana. AMB Express. 2014;4:53doi: 10.1186/s13568-014-0053-8.
Hung, R., Lee, S., Rodriguez-Saona, C., & Bennett, J. W. (2014). Common gas phase molecules from fungi affect seed germination and plant health in Arabidopsis thaliana. AMB Express, 453. https://doi.org/10.1186/s13568-014-0053-8
Hung, Richard, et al. "Common gas phase molecules from fungi affect seed germination and plant health in Arabidopsis thaliana." AMB Express vol. 4 (2014): 53. doi: https://doi.org/10.1186/s13568-014-0053-8
Hung R, Lee S, Rodriguez-Saona C, Bennett JW. Common gas phase molecules from fungi affect seed germination and plant health in Arabidopsis thaliana. AMB Express. 2014 Jul 15;4:53. doi: 10.1186/s13568-014-0053-8. eCollection 2014. PMID: 25045602; PMCID: PMC4100562.
Copy Download .nbib Format: NLM
A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.

Clinical and translational gastroenterology

Patel SJ, Luther J, Bohr S, Iracheta-Vellve A, Li M, King KR, Chung RT, Yarmush ML.
PMID: 26986653
Clin Transl Gastroenterol. 2016 Mar 17;7:e153. doi: 10.1038/ctg.2016.13.

OBJECTIVES: Acetaminophen (APAP)-induced hepatotoxicity is a major cause of morbidity and mortality. The current pharmacologic treatment for APAP hepatotoxicity, N-acetyl cysteine (NAC), targets the initial metabolite-driven injury but does not directly affect the host inflammatory response. Because of this,...

Cite
Patel SJ, Luther J, Bohr S, et al. A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity. Clin Transl Gastroenterol. 2016;7:e153doi: 10.1038/ctg.2016.13.
Patel, S. J., Luther, J., Bohr, S., Iracheta-Vellve, A., Li, M., King, K. R., Chung, R. T., & Yarmush, M. L. (2016). A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity. Clinical and translational gastroenterology, 7e153. https://doi.org/10.1038/ctg.2016.13
Patel, Suraj J, et al. "A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity." Clinical and translational gastroenterology vol. 7 (2016): e153. doi: https://doi.org/10.1038/ctg.2016.13
Patel SJ, Luther J, Bohr S, Iracheta-Vellve A, Li M, King KR, Chung RT, Yarmush ML. A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity. Clin Transl Gastroenterol. 2016 Mar 17;7:e153. doi: 10.1038/ctg.2016.13. PMID: 26986653; PMCID: PMC4822092.
Copy Download .nbib Format: NLM
Demethylating Agents in the Treatment of Cancer.

Pharmaceuticals (Basel, Switzerland)

Howell PM, Liu Z, Khong HT.
PMID: 27713340
Pharmaceuticals (Basel). 2010 Jul 02;3(7):2022-2044. doi: 10.3390/ph3072022.

Gene silencing resulting from aberrant DNA methylation can lead to tumorigenesis. Therefore, drugs that inhibit or interfere with DNA methylation have been used to reactivate and induce silenced gene re-expression in malignancies. Two demethylating agents, azacitidine and decitabine, are...

Cite
Howell PM, Liu Z, Khong HT. Demethylating Agents in the Treatment of Cancer. Pharmaceuticals (Basel). 2010;3(7):2022-2044doi: 10.3390/ph3072022.
Howell, P. M., Liu, Z., & Khong, H. T. (2010). Demethylating Agents in the Treatment of Cancer. Pharmaceuticals (Basel, Switzerland), 3(7), 2022-2044. https://doi.org/10.3390/ph3072022
Howell, Paul M, et al. "Demethylating Agents in the Treatment of Cancer." Pharmaceuticals (Basel, Switzerland) vol. 3,7 (2010): 2022-2044. doi: https://doi.org/10.3390/ph3072022
Howell PM, Liu Z, Khong HT. Demethylating Agents in the Treatment of Cancer. Pharmaceuticals (Basel). 2010 Jul 02;3(7):2022-2044. doi: 10.3390/ph3072022. PMID: 27713340; PMCID: PMC4036667.
Copy Download .nbib Format: NLM
Band Structure and Terahertz Optical Conductivity of Transition Metal Oxides: Theory and Application to CaRuO(3).

Physical review letters

Dang HT, Mravlje J, Georges A, Millis AJ.
PMID: 26382698
Phys Rev Lett. 2015 Sep 04;115(10):107003. doi: 10.1103/PhysRevLett.115.107003. Epub 2015 Sep 03.

Density functional plus dynamical mean field calculations are used to show that in transition metal oxides, rotational and tilting (GdFeO(3)-type) distortions of the ideal cubic perovskite structure produce a multiplicity of low-energy optical transitions which affect the conductivity down...

Cite
Dang HT, Mravlje J, Georges A, et al. Band Structure and Terahertz Optical Conductivity of Transition Metal Oxides: Theory and Application to CaRuO(3). Phys Rev Lett. 2015;115(10):107003doi: 10.1103/PhysRevLett.115.107003.
Dang, H. T., Mravlje, J., Georges, A., & Millis, A. J. (2015). Band Structure and Terahertz Optical Conductivity of Transition Metal Oxides: Theory and Application to CaRuO(3). Physical review letters, 115(10), 107003. https://doi.org/10.1103/PhysRevLett.115.107003
Dang, Hung T, et al. "Band Structure and Terahertz Optical Conductivity of Transition Metal Oxides: Theory and Application to CaRuO(3)." Physical review letters vol. 115,10 (2015): 107003. doi: https://doi.org/10.1103/PhysRevLett.115.107003
Dang HT, Mravlje J, Georges A, Millis AJ. Band Structure and Terahertz Optical Conductivity of Transition Metal Oxides: Theory and Application to CaRuO(3). Phys Rev Lett. 2015 Sep 04;115(10):107003. doi: 10.1103/PhysRevLett.115.107003. Epub 2015 Sep 03. PMID: 26382698.
Copy Download .nbib Format: NLM
A52 Development and evaluation of a viral-specific random PCR and next-generation sequencing based assay for detection and sequencing of hand, foot, and mouth disease pathogens.

Virus evolution

Anh NT, Thanh TT, Van HMT, Ngoc NM, Nhu LNT, Thanh LTM, Qui PT, Khanh TH, Nhan LNT, Viet HL, Viet DC, Tuan HM, Hung NT, Chau NVV, Thwaites G, van Doorn HR, Tan LV.
PMID: 28845247
Virus Evol. 2017 Mar 05;3. doi: 10.1093/ve/vew036.051. eCollection 2017 Mar.

No abstract available.

Cite
Anh NT, Thanh TT, Van HMT, et al. A52 Development and evaluation of a viral-specific random PCR and next-generation sequencing based assay for detection and sequencing of hand, foot, and mouth disease pathogens. Virus Evol. 2017;3doi: 10.1093/ve/vew036.051.
Anh, N. T., Thanh, T. T., Van, H. M. T., Ngoc, N. M., Nhu, L. N. T., Thanh, L. T. M., Qui, P. T., Khanh, T. H., Nhan, L. N. T., Viet, H. L., Viet, D. C., Tuan, H. M., Hung, N. T., Chau, N. V. V., Thwaites, G., van Doorn, H. R., & Tan, L. V. (2017). A52 Development and evaluation of a viral-specific random PCR and next-generation sequencing based assay for detection and sequencing of hand, foot, and mouth disease pathogens. Virus evolution, 3. https://doi.org/10.1093/ve/vew036.051
Anh, Nguyen To, et al. "A52 Development and evaluation of a viral-specific random PCR and next-generation sequencing based assay for detection and sequencing of hand, foot, and mouth disease pathogens." Virus evolution vol. 3 (2017). doi: https://doi.org/10.1093/ve/vew036.051
Anh NT, Thanh TT, Van HMT, Ngoc NM, Nhu LNT, Thanh LTM, Qui PT, Khanh TH, Nhan LNT, Viet HL, Viet DC, Tuan HM, Hung NT, Chau NVV, Thwaites G, van Doorn HR, Tan LV. A52 Development and evaluation of a viral-specific random PCR and next-generation sequencing based assay for detection and sequencing of hand, foot, and mouth disease pathogens. Virus Evol. 2017 Mar 05;3. doi: 10.1093/ve/vew036.051. eCollection 2017 Mar. PMID: 28845247; PMCID: PMC5565926.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 693 entries